HHSN261201500003I; HHSN26100081; 400.001.0081.0001; NCI-0D-frederick; appropriated; 125218 bldg. 560, building generator/ATS; 09/18/2018 09/25/2020
Ended Awarded Last action
- Contract number
- 75N91018F00081
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,560,250
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 100% obligated
- $2,560,250.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $522,563 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $2,037,687 |
About this award
The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on September 19, 2018, with a ceiling value of $2.56 million under a cost-plus-fixed-fee pricing structure. Ultimate completion date is September 1, 2023.
The order is a call against a cost-plus-fixed-fee indefinite delivery contract (HHSN261201500003I). Place of performance is Frederick, MD. The work involves building generator and automatic transfer switch support and maintenance at the Frederick National Laboratory for Cancer Research, Building 560.
Service Contract Inventory reporting shows Leidos Biomedical Research invoiced $313 thousand in FY2020, $73 thousand in FY2021 (0.1 FTEs, 173 hours), $724 thousand in FY2022 (1.9 FTEs, 4,046 hours), and $363 thousand in FY2023 (0.2 FTEs, 499 hours). The derived government-paid hourly rate rose from $424.45/hr in FY2021 to $726.41/hr in FY2023. In FY2023, the most recent reported period, Leidos self-performed all work with no subcontractors.
Quick answers
Who was awarded contract 75N91018F00081?
75N91018F00081 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 19, 2018.
How much is contract 75N91018F00081 worth?
The government has obligated $2,560,250 on 75N91018F00081.
Is contract 75N91018F00081 an order under another contract?
Yes. 75N91018F00081 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract 75N91018F00081 competed?
The extent of competition for 75N91018F00081 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award